- A peptide DNA report reads the file you already have against published research on the genes involved in how peptides act. It is education, not a diagnosis or a prescription.
- Consumer chips read a selection of positions, not your whole genome. Any file will be missing some markers, and a good report says which ones.
- Most genetic findings about peptides are associations from research on the pathway. They are not tests of the peptide in people with your genotype. For most peptides, no study has tested whether a genotype changes response.
- The strength of the evidence matters more than any single finding. A human study in people with a given genotype is very different from a pathway hypothesis or a preclinical result.
- A genetic report is not a basis for any medication or peptide decision. Chip results can be wrong, and medical decisions sit with a licensed clinician.
A peptide DNA report is easy to over-read. It names genes you have never heard of, ties them to compounds people talk about online, and invites the question "so what should I take?" That is the one question it cannot answer. This page explains how to read one carefully: what the results are, where their limits are, and what they are not for.
PeptidesDNA reports read the DNA file you already have against the published peptide research and show what it does and does not show. The principles below apply to any report of this kind, ours included.
The number of medication or peptide decisions a consumer genetic report should make on its own. Consumer chip results can be wrong, and the research behind most peptide findings is not strong enough to act on.
How to read the results
1. Coverage: what your file did and did not contain
Consumer DNA chips from 23andMe, AncestryDNA and MyHeritage read a pre-selected set of positions, not your whole genome, and different chip versions read different sets. Any report built on these files will be missing some markers. A careful report lists the markers it could not read, so you know which findings rest on less information than they could.
Some genes cannot be read reliably from chip data at all. CYP2D6, for example, varies through extra or missing copies of the whole gene, which consumer arrays cannot detect.
2. Associations are not predictions
Most published genetic findings take the form "people with this version of the gene had, on average, a slightly different level of X." That is an association across a population. It does not mean that you, carrying that version, will experience X. It also says nothing about a compound unless the study tested that compound.
For most peptides discussed online, no study has tested whether any genotype changes response. An honest report says so plainly for each compound. It does not turn pathway biology into a forecast.
"Your receptor gene is linked to differences in appetite" is an association. A claim about how a drug will act in one person with that gene would be a prediction. The first can be true while the second has never been tested.
3. The strength of the evidence matters most
Not all evidence behind a genetic finding is equal. In rough order of strength:
- A human study in people with the genotype, measuring response to the compound itself.
- A human study of the pathway, with no data on the compound by genotype.
- Preclinical work only, in cells or before any human testing.
- No data, where the link is a hypothesis drawn from how the compound is thought to work.
Most links between genes and peptides fall in the lower two groups. If you read a finding without its evidence level, you have read only half of it.
4. One marker rarely means much on its own
Common variants usually have small effects. A single marker linked to a trait in a large study shifts an average slightly. It does not decide an outcome for one person. Lifestyle, age, other genes and chance usually matter more.
5. Approved drugs and unapproved compounds are different questions
Some peptides are approved prescription drugs, such as semaglutide, tirzepatide, tesamorelin and bremelanotide. For these, decisions belong to the prescriber, who works from the label and your history. Most compounds discussed online, including BPC-157 and TB-500, are not approved for any use in people. A genetic result does not change either fact.
6. What a report is not for
A consumer genetic report about peptides is not a diagnosis or a treatment plan, and it is not a basis for any medication or peptide decision. If a result touches a medical question, a clinical test can confirm it, and a licensed clinician can interpret it.
The short version: a peptide DNA report is a map of what the research says about genes you carry, with the strength of that research attached. It shows what your file could not read, it treats associations as associations, and it is not a basis for any decision about a compound. To see how the evidence on individual compounds compares, go to the peptide reference library.
Frequently asked questions
Does a peptide DNA report make decisions about peptides?
No. It shows which versions of relevant genes you carry and what the published research on them does and does not show. For most peptides, no study has tested whether any genotype changes response, so a report cannot turn a genotype into a decision about any compound.
Why are some markers missing from my report?
Consumer DNA chips read a pre-selected set of positions, not your whole genome, and chip versions differ. A report cannot read markers that were not on your chip or were not called reliably. Some genes, such as CYP2D6, cannot be read reliably from chip data at all.
What is the difference between an association and a prediction?
An association means that people with a gene version had, on average, a different level of some trait in a study. A prediction would claim what will happen to you. Most genetic findings about peptides are associations from pathway research, and none of them has been tested as a prediction of response.
What role does a doctor play with a genetic report?
A consumer genetic report about peptides is not a basis for any medication or peptide decision. Consumer chip results can be wrong, so a clinical test is needed to confirm them, and medical decisions belong with a licensed clinician.
This article is for informational and educational purposes only. It reports what published research found; it is not medical advice, it does not diagnose, treat, cure or prevent any disease, and nothing in it is a dose or a recommendation to use any compound. Talk to a licensed clinician about any medical decision.